Basis of Presentation and Summary of Significant Accounting Policies (Tables)
|
9 Months Ended |
Sep. 30, 2023 |
|---|
| Basis of Presentation and Summary of Significant Accounting Policies |
|
| Schedule of fair value assets and liabilities measured on recurring basis |
|
|
|
|
|
Fair Value Measurement as of |
|
|
|
|
|
|
September 30, 2023 |
|
|
|
Total |
|
|
Level 1 |
|
|
Level 2 |
|
|
Level 3 |
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Profit share liability – related party (1) |
|
$ |
4,251,705 |
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
4,251,705 |
|
Total Liabilities |
|
$ |
4,251,705 |
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
4,251,705 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair Value Measurement as of |
|
|
|
|
|
|
|
December 31, 2022 |
|
|
|
Total |
|
|
Level 1 |
|
|
Level 2 |
|
|
Level 3 |
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Profit share liability – related party (1) |
|
$ |
3,638,260 |
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
3,638,260 |
|
Total Liabilities |
|
$ |
3,638,260 |
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
3,638,260 |
|
|
| Schedule of sales by operating segment disaggregated |
|
|
For the Three
Months Ended
September 30,
2023
|
|
|
For the Three
Months Ended
September 30,
2022
|
|
Product revenue |
|
$ |
6,672,542 |
|
|
$ |
7,382,800 |
|
License revenue |
|
|
52,500 |
|
|
|
52,530 |
|
Demonstrations & Consulting revenue |
|
|
27,000 |
|
|
|
27,000 |
|
Equipment revenue |
|
|
(4,786 |
) |
|
|
23,642 |
|
|
|
$ |
6,747,256 |
|
|
$ |
7,485,972 |
|
|
|
For the Nine
months ended September 30,
2023
|
|
|
For the Nine
months ended September 30,
2022
|
|
Product revenue |
|
$ |
13,103,653 |
|
|
$ |
15,372,155 |
|
License revenue |
|
|
671,250 |
|
|
|
285,938 |
|
Demonstrations & Consulting revenue |
|
|
81,000 |
|
|
|
81,000 |
|
Equipment revenue |
|
|
15,822 |
|
|
|
217,346 |
|
|
|
$ |
13,871,725 |
|
|
$ |
15,956,439 |
|
|
| Schedule of earnings per share basic and diluted |
|
|
September 30, |
|
|
September 30, |
|
|
|
2023 |
|
|
2022 |
|
|
|
|
|
|
|
|
Stock Options |
|
|
17,191,722 |
|
|
|
19,108,576 |
|
Warrants |
|
|
2,650,000 |
|
|
|
4,285,000 |
|
Total common stock equivalents excluded from basic and dilutive loss per share |
|
|
19,841,722 |
|
|
|
23,393,576 |
|
|
| Schedule of Weighted average common stock shares |
|
|
Three Months
Ended
September 30,
|
|
|
|
2022 |
|
|
|
|
|
Weighted average common stock outstanding |
|
|
89,871,132 |
|
Dilutive stock options (exercise price less than market price) at September 30, 2022 |
|
|
3,659,814 |
|
Total dilutive common stock equivalents outstanding |
|
|
93,530,946 |
|
|